Insulin resistance, acanthosis nigricans, and hypertriglyceridemia
- 28 February 2005
- journal article
- case report
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 52 (2), 341-344
- https://doi.org/10.1016/j.jaad.2004.10.867
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Genetic basis of congenital generalized lipodystrophyInternational Journal of Obesity, 2003
- Phenotypic and Genetic Heterogeneity in Congenital Generalized LipodystrophyJournal of Clinical Endocrinology & Metabolism, 2003
- Percentage body fat ranges associated with metabolic syndrome risk: results based on the third National Health and Nutrition Examination Survey (1988–1994)The American Journal of Clinical Nutrition, 2003
- AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34Nature Genetics, 2002
- Leptin-Replacement Therapy for LipodystrophyNew England Journal of Medicine, 2002
- Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13Nature Genetics, 2001
- Skeletal muscle triglyceride levels are inversely related to insulin actionDiabetes, 1997
- The role of neuropeptide Y in the antiobesity action of the obese gene productNature, 1995
- Positional cloning of the mouse obese gene and its human homologueNature, 1994
- Excess Insulin Binding to Insulin-Like Growth Factor Receptors: Proposed Mechanism for Acanthosis NigricansJournal of Investigative Dermatology, 1992